Nouvelle Clinique des Dentellières
- Address
- 8 Avenue Vauban, 59300 Valenciennes, France
Nouvelle Clinique des Dentellières - Head and Neck Cancer Research
Nouvelle Clinique des Dentellières is a specialized clinical research center focused on advancing treatment strategies for head and neck malignancies. The center demonstrates particular expertise in investigating innovative approaches that combine targeted immunotherapy with traditional radiation therapy modalities for patients with squamous cell carcinomas of the head and neck region.
- Combined immunotherapy and radiotherapy protocols for head and neck cancers
- Precision oncology targeting cervical lymph node management
- Tolerance and safety evaluation of novel therapeutic combinations
The research team specializes in evaluating treatment protocols for untreated squamous cell carcinoma of the head and neck, with a focus on optimizing regional cervical control while minimizing treatment burden. Their work emphasizes the integration of durvalumab-based immunotherapy with radiotherapy approaches, investigating selective tumor site irradiation strategies that may reduce prophylactic radiation exposure in patients with varying stages of disease presentation.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 29 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Nouvelle Clinique des Dentellières
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Durvalumab with FOLFOX and IMRT in Localized Unresectable Esophageal Adenocarcinoma or Squamous Cell Carcinoma: A Phase II Randomized Trial | Unicancer | Phase II | Not Recruiting | May 2019 | — |
IMP list
lock Showing 1 of 29 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Durvalumab | 3 | Unknown | 2019-03-21 | 2019-07-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.